首页> 外文期刊>Oral diseases >Use of systemic medication in patients with oral lichen planus - a possible association with hypothyroidism
【24h】

Use of systemic medication in patients with oral lichen planus - a possible association with hypothyroidism

机译:口腔扁平苔藓患者使用全身药物可能与甲状腺功能减退有关

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Several drugs have been regarded as a possible aetiological factor for oral lichen planus (OLP). OBJECTIVE: To investigate the medication profile of patients with OLP and its possible association with the pathogenesis of OLP. METHODS: Data from 956 patients with OLP and 1029 controls were collected using a standardized registration method. All regular medications were recorded and classified according to the Anatomical Therapeutic Chemical Classification System. RESULTS: Patients with OLP used thyroid preparations (P < 0.001) and non-steroidal anti-inflammatory drugs (NSAIDs) (P < 0.01) in higher proportions compared to controls. A multivariate logistic regression model demonstrated that levothyroxine was associated with OLP (multivariate OR 3.39, 95% Cl: 2.09-5.46, P< 0.001), even after controlling for confounders, including age, sex, smoking, allergies and systemic diseases. No statistical significance could be found between NSAIDs and OLP using the same model. CONCLUSION: In this study, the use of levothyroxine was associated with OLP, which in turn suggests a possible connection with hypothyroidism.
机译:背景:几种药物被认为是口腔扁平苔藓(OLP)的可能病因。目的:探讨OLP患者的用药情况及其与OLP发病机制的关系。方法:采用标准化注册方法收集了956名OLP患者和1029名对照的数据。记录所有常规药物并根据解剖治疗化学分类系统分类。结果:与对照组相比,OLP患者使用的甲状腺制剂(P <0.001)和非甾体抗炎药(NSAIDs)(P <0.01)的比例更高。多元逻辑回归模型表明,即使在控制了年龄,性别,吸烟,过敏和全身性疾病等混杂因素之后,左甲状腺素仍与OLP相关(多元OR 3.39,95%Cl:2.09-5.46,P <0.001)。使用相同模型,在NSAID和OLP之间未发现统计学意义。结论:在这项研究中,左甲状腺素与OLP有关,这反过来可能与甲状腺功能减退有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号